![](https://www.diabetesnews.com/wp-content/uploads/2014/05/pill-78915b8cd74585c6c282cabd78b904bc4a708dd8-s6-c30-150x150.jpg)
Compared with clinical trial subjects who took a placebo, those who added Jardiance to their regimen of diabetes medications were 38% less likely to die as a result of a heart attack, stroke or other cardiovascular problem during the approximately three years that subjects were tracked.